Načítá se...
Chikungunya virus: an update on antiviral development and challenges
Chikungunya virus (CHIKV) has re-emerged as a significant public health threat since the 2005 chikungunya fever epidemic in La Réunion. Driven by the medical importance of this virus, as well as the lack of approved antivirals, research into the field of CHIKV antivirals has recently intensified. Po...
Uloženo v:
| Vydáno v: | Drug Discov Today |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Ltd.
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7108317/ https://ncbi.nlm.nih.gov/pubmed/23684571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2013.05.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|